The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile acid composition

The biliary bile acid conjugation patterns were determined by high‐performance liquid chromatography in five subjects after 6 months of 500 mg per day of free ursodeoxycholic acid feeding. Prior to bile acid therapy, approximately 35% of the biliary bile acids were conjugated with taurine and approximately 65% were glycine conjugated, and ursodeoxycholic acid was either absent or, when present, accounted for less than 5% as the glycine conjugate. After 6 months, ursodeoxycholic acid became the major biliary bile acid and approximately 90% of it was present as the glycine conjugate and approximately 10% as the taurine conjugate. In another experiment, in seven patients, 1 gm per day of sodium tauroursodeoxycholate (equivalent to approximately 750 mg per day of free ursodeoxycholic acid and approximately 250 mg per day of taurine) was administered for 10 days. The proportion of tauroursodeoxycholic acid rose to 41% of the total biliary ursodeoxycholic acid but 59% still remained conjugated with glycine. When three patients were fed 1.5 gm per day of taurine together with 750 mg per day of free ursodeoxycholic acid for 10 days, the taurine conjugation of ursodeoxycholic acid and other bile acids increased to 29 to 40%. These studies show that the administration of free ursodeoxycholic acid results in the increased formation of glycour‐sodeoxycholic acid while the administration of 1 gm per day of tauroursodeoxycholic acid or 1.5 gm per day of taurine together with 750 mg per day of free ursodeoxycholic acid increases the excretion of tauroursodeoxycholic acid in the bile only to about 40% of the total biliary ursodeoxycholic acid. Thus, the taurine of tauroursodeoxycholic acid is partially lost during its enterohepatic circulation while the free taurine during taurine supplementation is only partially available for conjugation.

[1]  P. Czygan,et al.  URSODEOXYCHOLIC ACID AND GALLSTONE CALCIFICATION , 1981, The Lancet.

[2]  M. Plebani,et al.  Calcification of radiolucent gall stones during treatment with ursodeoxycholic acid. , 1981, British medical journal.

[3]  M. Une,et al.  Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis. , 1980, Journal of lipid research.

[4]  F. Nakayama,et al.  Quantitative determination of bile acids in bile with reversed-phase high-performance liquid chromatography. , 1980, Journal of chromatography.

[5]  G. Tint,et al.  Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans. , 1980, Gastroenterology.

[6]  B. Kommerell,et al.  Ursodeoxycholic acid versus chenodeoxycholic acid: Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones , 1978 .

[7]  M. Carey Critical tables for calculating the cholesterol saturation of native bile. , 1978, Journal of lipid research.

[8]  W. Hardison Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. , 1978, Gastroenterology.

[9]  C. Bloch,et al.  Determination of conjugated bile acids in human bile and duodenal fluid by reverse-phase high-performance liquid chromatography. , 1978, Journal of lipid research.

[10]  J. C. Hall,et al.  Metabolism of ursodeoxycholic acid in man. , 1977, Gastroenterology.

[11]  P. Klein,et al.  An improved procedure for the synthesis of glycine and taurine conjugates of bile acids. , 1977, Journal of lipid research.

[12]  G. Tint,et al.  A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain. , 1974, The Journal of clinical investigation.

[13]  K. Mashimo,et al.  Measurement of sulfated and nonsulfated bile acids in human serum and urine. , 1974, Journal of lipid research.

[14]  G. Tint,et al.  Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid. , 1974, The Journal of clinical investigation.

[15]  J. Thistle,et al.  Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis. , 1973, The Journal of clinical investigation.

[16]  S. Grundy,et al.  The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis. , 1973, The Journal of clinical investigation.

[17]  S. Shefer,et al.  Regulatory effects of sterols and bile acids on hepatic 3-hydroxy-3-methylglutaryl CoA reductase and cholesterol 7alpha-hydroxylase in the rat. , 1973, Journal of lipid research.

[18]  A. Hofmann,et al.  Metabolism of steroid and amino acid moieties of conjugated bile acids in man. 3. Cholyltaurine (taurocholic acid). , 1973, The Journal of clinical investigation.

[19]  G. Salen Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism. , 1971, Annals of internal medicine.

[20]  J. Sjövall Dietary Glycine and Taurine on Bile Acid Conjugation in Man.∗ † Bile Acids and Steroids 75 , 1959 .

[21]  P. S. Chen,et al.  Microdetermination of Phosphorus , 1956 .

[22]  M. Carey,et al.  pH-Solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena. , 1980, Journal of lipid research.

[23]  A. Nowotny Microdetermination of Phosphorus , 1979 .

[24]  F. Hofmann,et al.  Metabolism of Steroid and Amino Acid , 1973 .

[25]  A. Gottfries,et al.  The capacity of human liver homogenates to synthesize taurocholic and glycocholic acid in vitro. , 1966, Scandinavian journal of clinical and laboratory investigation.

[26]  J. Sjovall Dietary glycine and taurine on bile acid conjugation in man; bile acids and steroids 75. , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.